LakeShore Biopharma Co. L... (LSB)

NASDAQ: LSB · Real-Time Price · USD

1.19

-0.06 (-4.80%)

At close: May 02, 2025, 3:57 PM

1.18

-0.84%

After-hours: May 02, 2025, 04:57 PM EDT

LakeShore Biopharma Ltd Cash Flow Statement

Financials in CNY. Fiscal year is April - March.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Period Ending	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Net Income	-181.41M	-77.62M	-105.02M	-69.42M	-111.07M	-88.71M	-29.25M	11.52M	45.27M	19.74M	6.68M	-30.24M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	9.8M	n/a	n/a	n/a	3.51M	84.76K	-85.64K	n/a	n/a	n/a	n/a	n/a
Other Working Capital	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.05M	436.57K	714.43K	-3.75M	n/a
Other Non-Cash Items	171.61M	77.62M	105.02M	69.42M	107.56M	88.63M	29.34M	-14.26M	-46.76M	-21.66M	-7.98M	32.58M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.05M	436.58K	714.43K	-3.75M	n/a
Operating Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-693.96K	-1.05M	-1.2M	-5.06M	2.34M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	734.02K	1.43M	-1.29B
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	734.02K	1.43M	-1.29B
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.32K	-1.42M	21.97M
Financial Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-739.52K	-1.45M	1.3B
Net Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-698.7K	-1.05M	-1.21M	-5.06M	12.02M
Free Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-693.96K	-1.05M	-1.2M	-5.06M	2.34M